Nectar Lifesciences (LUX:NECLF) 3-Year Revenue Growth Rate : 2.50% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Nectar Lifesciences 3-Year Revenue Growth Rate?

Nectar Lifesciences's Revenue per Share for the three months ended in Mar. 2024 was $0.21.

During the past 12 months, Nectar Lifesciences's average Revenue per Share Growth Rate was 9.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -10.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Nectar Lifesciences was 22.90% per year. The lowest was -15.70% per year. And the median was 8.10% per year.

Competitive Comparison of Nectar Lifesciences's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nectar Lifesciences's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's 3-Year Revenue Growth Rate falls into.

Nectar Lifesciences 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Nectar Lifesciences (LUX:NECLF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Nectar Lifesciences 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nectar Lifesciences (LUX:NECLF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (LUX:NECLF) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

NECLIFE:India 532649:India

Address

SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009

Website

https://www.neclife.com

Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (LUX:NECLF) Headlines

No Headlines